These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36806572)

  • 1. Scouting Different Phosphodiesterase 4 Inhibitor Chemotypes in Silico To Guide the Design of Anti-inflammatory/Antioxidant Agents.
    Cichero E; Rapetti F; Lusardi M; Scarano N; Alfei S; Altieri P; Garibaldi S; Ameri P; Grazia Signorello M; Brullo C
    ChemMedChem; 2023 May; 18(9):e202300046. PubMed ID: 36806572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of a novel class of PDE4 inhibitors with antioxidant properties as bifunctional agents for the potential treatment of COPD.
    Wang Y; Wang H; Yang G; Hao Q; Yang K; Shen H; Wang Y; Wang J
    Eur J Med Chem; 2023 Aug; 256():115374. PubMed ID: 37150057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3-Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7.
    Sharma H; Lather V; Grewal AS; Pandita D
    Curr Comput Aided Drug Des; 2019; 15(3):225-234. PubMed ID: 30280674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Docking and Anti-Inflammatory Activity of Triazole Amine Derivatives as Potential Phosphodiesterase-4 Inhibitors.
    Grewal AS; Lather V; Pandita D; Dalal R
    Antiinflamm Antiallergy Agents Med Chem; 2017; 16(1):58-67. PubMed ID: 28618988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: Design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings.
    Zhou ZZ; Ge BC; Zhong QP; Huang C; Cheng YF; Yang XM; Wang HT; Xu JP
    Eur J Med Chem; 2016 Nov; 124():372-379. PubMed ID: 27597413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of selective phosphodiesterase 4B inhibitors based on ginger phenolic compounds.
    Xing M; Akowuah GA; Gautam V; Gaurav A
    J Biomol Struct Dyn; 2017 Oct; 35(13):2910-2924. PubMed ID: 27608741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholic amides as potential selective phosphodiesterase 4D inhibitors: Design, synthesis, pharmacological evaluation and structure-activity relationships.
    Zhou ZZ; Ge BC; Chen YF; Shi XD; Yang XM; Xu JP
    Bioorg Med Chem; 2015 Nov; 23(22):7332-9. PubMed ID: 26526739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 2-(3,4-dialkoxyphenyl)-2-(substituted pyridazin-3-yl)acetonitriles as phosphodiesterase 4 inhibitors with anti-neuroinflammation potential based on three-dimensional quantitative structure-activity relationship study.
    Huang C; Zhong QP; Tang L; Wang HT; Xu JP; Zhou ZZ
    Chem Biol Drug Des; 2019 Apr; 93(4):484-502. PubMed ID: 30588755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis.
    Purushothaman B; Arumugam P; Kulsi G; Song JM
    Eur J Med Chem; 2018 Feb; 145():673-690. PubMed ID: 29353721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CuCl
    Thirupataiah B; Mounika G; Sujeevan Reddy G; Sandeep Kumar J; Kapavarapu R; Medishetti R; Mudgal J; Mathew JE; Shenoy GG; Mallikarjuna Rao C; Chatti K; V L Parsa K; Pal M
    Bioorg Chem; 2021 Oct; 115():105265. PubMed ID: 34426160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastereoselective synthesis and profiling of bicyclic imidazolidinone derivatives bearing a difluoromethylated catechol unit as potent phosphodiesterase 4 inhibitors.
    Dorokhov VS; Golovanov IS; Tartakovsky VA; Sukhorukov AY; Ioffe SL
    Org Biomol Chem; 2018 Oct; 16(38):6900-6908. PubMed ID: 30024008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacophore modeling and virtual screening for the discovery of new type 4 cAMP phosphodiesterase (PDE4) inhibitors.
    Niu M; Dong F; Tang S; Fida G; Qin J; Qiu J; Liu K; Gao W; Gu Y
    PLoS One; 2013; 8(12):e82360. PubMed ID: 24340020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment.
    Brullo C; Ricciarelli R; Prickaerts J; Arancio O; Massa M; Rotolo C; Romussi A; Rebosio C; Marengo B; Pronzato MA; van Hagen BTJ; van Goethem NP; D'Ursi P; Orro A; Milanesi L; Guariento S; Cichero E; Fossa P; Fedele E; Bruno O
    Eur J Med Chem; 2016 Nov; 124():82-102. PubMed ID: 27560284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological Targets.
    Brullo C; Massa M; Rapetti F; Alfei S; Bertolotto MB; Montecucco F; Signorello MG; Bruno O
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32085423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking Studies of Curcumin and Analogues with Various Phosphodiesterase 4 Subtypes.
    Yi YX; Gaurav A; Akowuah GA
    Curr Drug Discov Technol; 2020; 17(2):248-260. PubMed ID: 30332967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
    Tripuraneni NS; Azam MA
    J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sappanone A: A natural PDE4 inhibitor with dual anti-inflammatory and antioxidant activities from the heartwood of Caesalpinia sappan L.
    Wang YZ; Wang YL; Che HJ; Jia YH; Wang HF; Zuo LF; Yang K; Li TT; Wang JX
    J Ethnopharmacol; 2023 Mar; 304():116020. PubMed ID: 36529254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4).
    Cameron RT; Coleman RG; Day JP; Yalla KC; Houslay MD; Adams DR; Shoichet BK; Baillie GS
    Biochem Pharmacol; 2013 May; 85(9):1297-305. PubMed ID: 23473803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A yeast-based chemical screen identifies a PDE inhibitor that elevates steroidogenesis in mouse Leydig cells via PDE8 and PDE4 inhibition.
    Demirbas D; Wyman AR; Shimizu-Albergine M; Cakici O; Beavo JA; Hoffman CS
    PLoS One; 2013; 8(8):e71279. PubMed ID: 23967182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel quinazoline-based anti-inflammatory agents acting as PDE4B inhibitors.
    Serya RA; Abbas AH; Ismail NS; Esmat A; Abou El Ella DA
    Chem Pharm Bull (Tokyo); 2015; 63(2):102-16. PubMed ID: 25748781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.